CopyMark Law Group
4.9/5
Drawing for BENEBIOSE

USPTO serial 79330136

BENEBIOSE

Reviewed by CopyMark Law Group

Reg. 7171695Status 700Registered
Filing date
Status date
Registration date
Sep 26, 2023
Examiner
DAVIS, MARC STEPHEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BENEBIOSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James C. Watson

James C. Watson TraskBritt, P.C.230 South 500 East, #300Salt Lake City, UT 84103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals, namely, specialty carbohydrates, complex sugars, oligosaccharides and rare monosaccharides, all produced by innovative bio-technological processes and for use in the food, feed, cosmetic, nutraceutical and pharmaceutical industries and for use in science as well as in agriculture, all the foregoing not including fungicides, herbicides, insecticides and parasiticides; specialty carbohydrate and human milk oligosaccharide preparations being additives for use in the food industry and for use as raw material in the manufacture of cosmetics; human milk oligosaccharide being additives for use in the manufacture of pharmaceuticals, nutraceuticals, infant formula, foodstuffs and of animal foods; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds, all being chemicals for use in the manufacture of food; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds, all being chemicals for scientific use excluding medical or veterinary use; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds, all being chemicals for industrial use; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds, all for food use in the manufacture of pharmaceuticals, nutraceuticals, infant formula, foodstuffs and of animal foods; chemicals for industrial use, and for use as a chemical ingredient in the preparation of dietary supplements and of infant formulaACTIVE—
003Cosmetics containing specialty carbohydratesACTIVE—
005Pharmaceutical and veterinary preparations, namely, medicated skincare preparations; dietetic foods adapted for medical use; formulated milk, food and food substances, all for babies; infant formula, namely, growing up formula; beverages for babies, namely, liquid formula milk; dietetic drinks for babies for medical use; dietetic drinks for infants, children and toddlers, for medical use; dietetic food and dietetic food substances for children and invalids, all adapted for medical use; nutritional and dietary supplements adapted for medical use; dietetic food for special medical purposes; pharmaceuticals and medical products for human use, namely, skincare preparations; sanitary preparations for medical purposes; medical preparations for the treatment of the skin and hair; medical dermatological preparations; biotechnological products for medical use, for human beings, namely, bone growth media consisting of biological materials for medical purposes; medical preparations and medical products in tablet form for the treatment of heart disease; herbal tinctures for medical purposes; ointments for pharmaceutical purposes, namely, medicated ointments for treating dermatological conditions; pharmaceutical skin lotions; capsules for pharmaceutical purposes for the treatment of skin condition; pharmaceutical preparations for skin care; pharmaceutical and veterinary specialty carbohydrate based preparations for the treatment of skin condition; nutritional supplements; medical plasters; dressings for burns and wounds; surgical dressings; material for stopping teeth; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides; nutritional drinks in the nature of food supplements; nutritionally enhanced fruit juices and fruit juice-based products, all for medical purposes; nutritionally enhanced milk for medical purposes; nutritionally enhanced mineral and aerated waters, for medical purposes; nutritionally enhanced lotions, salves and balms, all for medical dermatological use; nutritionally fortified water for medical use; nutritional powders and bars in the nature of food supplements; food supplements in the form of nutritional bars and in powder form, for use in making nutritional shakes; nutritional and dietary supplements, in powder, capsule, tablets, gels, partially and fully reconstituted liquids and bar form; meal replacements in bar, powder and liquid form in the nature of food supplements; dietetic foods and beverages for medical use; food supplements prepared for human consumption for medical use; nutritional beverages in powder form or in liquid form in the nature of food supplements; fortifying food supplements; restorative food supplements; mineral food supplements; colostrum food supplements; dietary supplemental drinks in the nature of food supplements; mineral, vitamin or nutritionally enhanced water, for medical use; nutritionally fortified beverages for medical use; dietetic foods and beverages and strengthening dietetic foods and substances, all adapted for medical use, particularly for clinical use; food additives for baby and animals, namely, specialty carbohydrate and human milk oligosaccharide for medical use; veterinary products for animal health, namely, skincare preparations; medicated oral health care products, namely, gels; dietary supplements for humans and animals; dietetic food and beverages adapted for biomedical or veterinary use; medicated additives and supplements for animal nutrition; medicated biochemicals in the nature of food additives for animal feed and nutrition; dietetic food and substances, namely, specialty carbohydrate and human milk oligosaccharide adapted for medical or veterinary use; medicated food additives in the nature of dietary supplements containing human milk oligosaccharide for humans and for animals; medicated preparations for use as additives for food for human or animal consumption, namely, human milk oligosaccharide for medical or veterinary purposes; vitamin supplements for dietary use; food supplements for dietetic use; dietary supplements for medical use; medicated supplements for foodstuffs for humans, particularly for infants and for animals; dietary supplemental drinks for medical use; dietary supplements for infants; human milk oligosaccharide dietary supplements; human milk oligosaccharide compounds for medical skincare purposes; human milk oligosaccharide additives being dietary and nutritional supplements for use as supplements in connection with pharmaceuticals, nutraceuticals and with infant formula; human milk oligosaccharide additives for use as a dietary or nutritional supplement; human milk oligosaccharide compounds and chemical and biological derivatives of human milk oligosaccharide compounds, all for medical skincare useACTIVE—
029Dairy products, namely, cream, ice cream, ice milk, frozen yoghurt; milk; milk powder; flavoured jellified milk and whipped milk; dairy based desserts, namely, dairy-based chocolate food beverages, dairy-based vanilla food beverages; yoghurts; drinking yoghurts; dairy based mousses and creams; dairy fresh cream; butter, cheese spreads, cheese, ripened cheese, mould-ripened cheese, fresh unripened cheese and cheese in brine; soft white cheese; strained soft white cheese; plain and aromatised fresh cheese in pasty or liquid form; beverages primarily consisting of milk and dairy products; milk beverages containing fruits; plain and flavoured fermented dairy products, namely, cheese; milk-based beverages containing lactic ferments, not for medical useACTIVE—
030Specialty carbohydrate and human milk oligosaccharide preparations for culinary purposes, namely, carbohydrate dairy based mixes for making bakery goods, sauces, ice creams, and beverages with a chocolate base, cocoa base, coffee base, tea base, or grain base; specialty carbohydrate and human milk oligosaccharide compounds and chemical and biological derivatives of human milk oligosaccharide compounds for culinary purposes, namely, carbohydrate dairy based mix for making bakery goods, sauces, ice creams, and beverages with a chocolate base, cocoa base, coffee base, tea base, or grain base; processed cereals for human consumption; cereal preparations, namely, ready-to-eat cereals, breakfast cereals and cereals bars for human consumption; coffee; tea; confectionery, namely, frozen confectionariesACTIVE—
031Animal food; animal feed and feedstuffsACTIVE—
032Beers; mineral and aerated waters and other non- alcoholic drinks, namely, fruit juices, vegetable juices, energy drinks, isotonic beverages, soft drinks, malt beverages; fruit drinks and fruit juices; syrups and other preparations for making lemonade, soft drinks, energy drinks, non-alcoholic fruit-juice beverages, flavoured mineral waters, whey-based beverages, isotonic beverages, malt beverages, non-alcoholic fruit-flavoured beverages; soft drinks containing small quantities of dairy products; non-alcoholic water-based beverages containing small quantities of lactic ferments; non-alcoholic carbonated beverages containing small quantities of lactic ferments; non-alcoholic beverages containing fruit juices; non- alcoholic fruit nectars; natural fruit juices without additives; apple juices, grape juices, orange juices, pineapple juices, grapefruit juices, cherry juices, prune juices, peach juices, apricot juices, apple and black currant juices, apple and cherry juices, mixed fruit juices; vegetable juices, tomato juices, carrot juices and apple and carrot juices, all being beverages; light non-alcoholic beverage, namely, fruit juices; nutritionally fortified beverages in the nature of fruit drinks and fruit juices; nutritionally fortified drinking water and soft drinks in the nature of beverages; sports drinks; drinking water with vitamins; flavoured drinking water nutritionally enhanced with vitamins and minerals; sports drinks containing electrolytes, vitamins and minerals; performance enhancing nutritionally fortified beverages, not for medical use, namely, sports drinksACTIVE—
042Scientific and technological research and design in the field of biotechnology relating to carbohydrate and specialty carbohydrate production; industrial analysis, namely, design and development of production facilities for production of specialty carbohydrate and human milk oligosaccharide, and scientific research services in the field of biotechnology relating to carbohydrate and specialty carbohydrate production; design and development of upstream and downstream processing in the production of carbohydrates and specialty carbohydrates; scientific, biotechnological and technological evaluation and development in the field of carbohydrate and specialty carbohydrate production, namely, evaluation of the goods and services of others to assure compliance with industry standards and to determine conformity with certification standards; research and development of new specialty carbohydrate products; scientific research related to biomedical issues and to issues on clinical nutrition, prebiotics, cosmetics, crop protection, plant disease and on fertilization management; industrial and scientific research in the field of biotechnology and specialty carbohydratesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 13, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 27, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 27, 2023FIMPFINAL DISPOSITION PROCESSED—
Dec 26, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 26, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 26, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 11, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 11, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 10, 2023GPNXNOTIFICATION PROCESSED BY IB—
Jun 21, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 21, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 21, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 19, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 2, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 2, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jun 2, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 2, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 2, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
May 31, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 31, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 11, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 11, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 11, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2023RFNPREFUSAL PROCESSED BY IB—
Dec 9, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 8, 2022RFRRREFUSAL PROCESSED BY MPU—
Sep 28, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2022DOCKASSIGNED TO EXAMINER—
Aug 27, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 8, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 4, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 30, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance